Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Peptide-based Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Peptide-based Drug market. Detailed analysis of key players, along with key growth strategies adopted by Peptide-based Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Merck
AstraZeneca
Takeda
Eli Lilly
AbbVie
Ipsen
Teva
Novo Nordisk
Ferring
The Medicines
J & J
Novartis
By Type:
Injection
Oral
Other
By End-User:
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide-based Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Peptide-based Drug Market Size and Growth Rate of Injection from 2016 to 2027
-
1.3.2 China Peptide-based Drug Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.3 China Peptide-based Drug Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Peptide-based Drug Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.2 China Peptide-based Drug Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027
-
1.4.3 China Peptide-based Drug Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
1.4.4 China Peptide-based Drug Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Peptide-based Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptide-based Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Injection
-
3.4.2 Market Size and Growth Rate of Oral
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Peptide-based Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptide-based Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Peptide-based Drug in Cancer
-
4.4.2 Market Size and Growth Rate of Peptide-based Drug in Metabolic Disorders
-
4.4.3 Market Size and Growth Rate of Peptide-based Drug in Central Nervous System
-
4.4.4 Market Size and Growth Rate of Peptide-based Drug in Other
5 Market Analysis by Regions
-
5.1 China Peptide-based Drug Production Analysis by Regions
-
5.2 China Peptide-based Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Peptide-based Drug Landscape Analysis
-
6.1 North China Peptide-based Drug Landscape Analysis by Major Types
-
6.2 North China Peptide-based Drug Landscape Analysis by Major End-Users
7 Central China Peptide-based Drug Landscape Analysis
-
7.1 Central China Peptide-based Drug Landscape Analysis by Major Types
-
7.2 Central China Peptide-based Drug Landscape Analysis by Major End-Users
8 South China Peptide-based Drug Landscape Analysis
-
8.1 South China Peptide-based Drug Landscape Analysis by Major Types
-
8.2 South China Peptide-based Drug Landscape Analysis by Major End-Users
9 East China Peptide-based Drug Landscape Analysis
-
9.1 East China Peptide-based Drug Landscape Analysis by Major Types
-
9.2 East China Peptide-based Drug Landscape Analysis by Major End-Users
10 Northeast China Peptide-based Drug Landscape Analysis
-
10.1 Northeast China Peptide-based Drug Landscape Analysis by Major Types
-
10.2 Northeast China Peptide-based Drug Landscape Analysis by Major End-Users
11 Southwest China Peptide-based Drug Landscape Analysis
-
11.1 Southwest China Peptide-based Drug Landscape Analysis by Major Types
-
11.2 Southwest China Peptide-based Drug Landscape Analysis by Major End-Users
12 Northwest China Peptide-based Drug Landscape Analysis
-
12.1 Northwest China Peptide-based Drug Landscape Analysis by Major Types
-
12.2 Northwest China Peptide-based Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Sanofi
-
13.1.1 Sanofi Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Merck
-
13.2.1 Merck Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AstraZeneca
-
13.3.1 AstraZeneca Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Takeda
-
13.4.1 Takeda Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Eli Lilly
-
13.5.1 Eli Lilly Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 AbbVie
-
13.6.1 AbbVie Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Ipsen
-
13.7.1 Ipsen Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Teva
-
13.8.1 Teva Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Novo Nordisk
-
13.9.1 Novo Nordisk Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Ferring
-
13.10.1 Ferring Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 The Medicines
-
13.11.1 The Medicines Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 J & J
-
13.12.1 J & J Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Novartis
-
13.13.1 Novartis Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Peptide-based Drug Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure China Peptide-based Drug Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Peptide-based Drug Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Peptide-based Drug Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure China Peptide-based Drug Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027
-
Figure China Peptide-based Drug Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
Figure China Peptide-based Drug Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Peptide-based Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Peptide-based Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Peptide-based Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptide-based Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Peptide-based Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Injection
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Peptide-based Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Peptide-based Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Metabolic Disorders
-
Figure Market Size and Growth Rate of Central Nervous System
-
Figure Market Size and Growth Rate of Other
-
Table China Peptide-based Drug Production by Regions
-
Table China Peptide-based Drug Production Share by Regions
-
Figure China Peptide-based Drug Production Share by Regions in 2016
-
Figure China Peptide-based Drug Production Share by Regions in 2021
-
Figure China Peptide-based Drug Production Share by Regions in 2027
-
Table China Peptide-based Drug Consumption by Regions
-
Table China Peptide-based Drug Consumption Share by Regions
-
Figure China Peptide-based Drug Consumption Share by Regions in 2016
-
Figure China Peptide-based Drug Consumption Share by Regions in 2021
-
Figure China Peptide-based Drug Consumption Share by Regions in 2027
-
Table North China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table North China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Peptide-based Drug Consumption Share by Types in 2016
-
Figure North China Peptide-based Drug Consumption Share by Types in 2021
-
Figure North China Peptide-based Drug Consumption Share by Types in 2027
-
Table North China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table North China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure North China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure North China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table Central China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table Central China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Peptide-based Drug Consumption Share by Types in 2016
-
Figure Central China Peptide-based Drug Consumption Share by Types in 2021
-
Figure Central China Peptide-based Drug Consumption Share by Types in 2027
-
Table Central China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure Central China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure Central China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table South China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table South China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Peptide-based Drug Consumption Share by Types in 2016
-
Figure South China Peptide-based Drug Consumption Share by Types in 2021
-
Figure South China Peptide-based Drug Consumption Share by Types in 2027
-
Table South China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table South China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure South China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure South China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table East China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table East China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Peptide-based Drug Consumption Share by Types in 2016
-
Figure East China Peptide-based Drug Consumption Share by Types in 2021
-
Figure East China Peptide-based Drug Consumption Share by Types in 2027
-
Table East China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table East China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure East China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure East China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table Northeast China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Peptide-based Drug Consumption Share by Types in 2016
-
Figure Northeast China Peptide-based Drug Consumption Share by Types in 2021
-
Figure Northeast China Peptide-based Drug Consumption Share by Types in 2027
-
Table Northeast China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table Southwest China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Peptide-based Drug Consumption Share by Types in 2016
-
Figure Southwest China Peptide-based Drug Consumption Share by Types in 2021
-
Figure Southwest China Peptide-based Drug Consumption Share by Types in 2027
-
Table Southwest China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table Northwest China Peptide-based Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Peptide-based Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Peptide-based Drug Consumption Share by Types in 2016
-
Figure Northwest China Peptide-based Drug Consumption Share by Types in 2021
-
Figure Northwest China Peptide-based Drug Consumption Share by Types in 2027
-
Table Northwest China Peptide-based Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Peptide-based Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Peptide-based Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Peptide-based Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Peptide-based Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Ipsen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen
-
Figure Sales and Growth Rate Analysis of Ipsen
-
Figure Revenue and Market Share Analysis of Ipsen
-
Table Product and Service Introduction of Ipsen
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Ferring
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring
-
Figure Sales and Growth Rate Analysis of Ferring
-
Figure Revenue and Market Share Analysis of Ferring
-
Table Product and Service Introduction of Ferring
-
Table Company Profile and Development Status of The Medicines
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Medicines
-
Figure Sales and Growth Rate Analysis of The Medicines
-
Figure Revenue and Market Share Analysis of The Medicines
-
Table Product and Service Introduction of The Medicines
-
Table Company Profile and Development Status of J & J
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of J & J
-
Figure Sales and Growth Rate Analysis of J & J
-
Figure Revenue and Market Share Analysis of J & J
-
Table Product and Service Introduction of J & J
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
